Macquarie Group LTD Royalty Pharma PLC Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Macquarie Group LTD holds 46,788 shares of RPRX stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,788

Previous 46,788 -0.0%

Holding current value

$1.14 Million

Previous $1.23 Million 7.3%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$26.26 - $29.9 $27,888 - $31,753	1,062 Added 2.32%	46,788 $1.23 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $241,577 - $269,320	9,217 Added 25.25%	45,726 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $480,663 - $574,379	18,304 Added 100.54%	36,509 $990,000
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $265,867 - $328,381	8,982 Added 97.39%	18,205 $559,000
Q4 2022 Feb 21, 2023	BUY	$39.17 - $44.04 $84,019 - $94,465	2,145 Added 30.31%	9,223 $364,000
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $97,586 - $109,258	2,447 Added 52.84%	7,078 $285,000
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $72,297 - $81,909	1,930 Added 71.46%	4,631 $180,000
Q4 2021 Feb 11, 2022	SELL	$35.17 - $42.48 $83,704 - $101,102	-2,380 Reduced 46.84%	2,701 $107,000
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $5,459 - $6,388	137 Added 2.77%	5,081 $209,000
Q1 2021 May 14, 2021	BUY	$42.34 - $52.82 $124,648 - $155,502	2,944 Added 147.2%	4,944 $216,000
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $72,240 - $100,100	2,000 New	2,000 $100,000

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Royalty Pharma PLC Transaction History